CC-292

· Celgene Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CC-292, covering 2016-04-19 to 2018-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma [Phase 1]

See pricing